Love in the time of cholera.
- Published in:
- Asia Weekly, 2008, v. 2, n. 32, p. 37
- Publication type:
- Article
Works matching DE "CRUCELL NV"
Results: 14
1
2
J&J swoops on Crucell.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 832, p. 9
- Publication type:
- Article
3
analysis.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 821, p. 4
- Publication type:
- Article
4
News in brief.
- Published in:
- Nature Medicine, 2010, v. 16, n. 5, p. 502, doi. 10.1038/nm0510-502
- Publication type:
- Article
5
Ebola vaccine gets corporate backer.
- Published in:
- Nature Medicine, 2002, v. 8, n. 7, p. 645, doi. 10.1038/nm0702-645b
- By:
- Publication type:
- Article
6
Biotech milestonc.
- Published in:
- Chemical Engineering, 2008, v. 115, n. 12, p. 16
- Publication type:
- Article
7
J&J deal for vaccine maker.
- Published in:
- Chemistry & Industry, 2010, n. 20, p. 6
- By:
- Publication type:
- Article
8
Research briefs.
- Published in:
- Chemistry & Industry, 2007, n. 24, p. 10
- Publication type:
- Article
9
In brief.
- Published in:
- Nature, 2005, v. 438, n. 7069, p. 737, doi. 10.1038/438737a
- Publication type:
- Article
10
Crucell NV: Results for the year ended 31st December, 2003.
- Published in:
- Journal of Commercial Biotechnology, 2004, v. 11, n. 1, p. 98
- Publication type:
- Article
11
Will J&J turbocharge Crucell's vaccine portfolio?
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 12, p. 1223, doi. 10.1038/nbt1210-1223
- By:
- Publication type:
- Article
12
People.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 12, p. 1521, doi. 10.1038/nbt1203-1521
- Publication type:
- Article
13
Cash crunch quells antibody litigation.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 114, doi. 10.1038/nbt0203-114
- By:
- Publication type:
- Article
14
News.
- Published in:
- Medical Laboratory Observer (MLO), 2003, v. 35, n. 10, p. 8
- Publication type:
- Article